ibi351
GenFleet Therap,innovent biologics
['kvi,(-kviii)', 'ibi351', 'solid tumor', 'innovent']
dcbn news: innovent announces updated data of phase 1 clinical trial for ibi351 (kras[g12c] inhibitor) as monotherapy for solid tumors at the aacr annual meeting 2023: rockville, md. and suzhou, china, april ... #biotech #news 
Life science news and jobs from Washington DC, Maryland and Virginia. Part of @BiotechNetworks, connecting #biotech since 2008.